These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 29563789)
1. Pomegranate extract-loaded solid lipid nanoparticles: design, optimization, and in vitro cytotoxicity study. Badawi NM; Teaima MH; El-Say KM; Attia DA; El-Nabarawi MA; Elmazar MM Int J Nanomedicine; 2018; 13():1313-1326. PubMed ID: 29563789 [TBL] [Abstract][Full Text] [Related]
2. Natamycin solid lipid nanoparticles - sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization. Khames A; Khaleel MA; El-Badawy MF; El-Nezhawy AOH Int J Nanomedicine; 2019; 14():2515-2531. PubMed ID: 31040672 [TBL] [Abstract][Full Text] [Related]
3. Development of Pomegranate Extract-Loaded Solid Lipid Nanoparticles: Quality by Design Approach to Screen the Variables Affecting the Quality Attributes and Characterization. Badawi N; El-Say K; Attia D; El-Nabarawi M; Elmazar M; Teaima M ACS Omega; 2020 Sep; 5(34):21712-21721. PubMed ID: 32905321 [TBL] [Abstract][Full Text] [Related]
4. Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin. Abul Kalam M; Sultana Y; Ali A; Aqil M; Mishra AK; Aljuffali IA; Alshamsan A J Biomed Mater Res A; 2013 Jun; 101(6):1813-27. PubMed ID: 23255511 [TBL] [Abstract][Full Text] [Related]
7. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity. Baig MS; Ahad A; Aslam M; Imam SS; Aqil M; Ali A Int J Biol Macromol; 2016 Apr; 85():258-70. PubMed ID: 26740466 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of pomegranate extract loaded solid lipid nanoparticles transdermal emulgel against Ehrlich ascites carcinoma. Teaima MH; Badawi NM; Attia DA; El-Nabarawi MA; Elmazar MM; Mousa SA Nanomedicine; 2022 Jan; 39():102466. PubMed ID: 34587542 [TBL] [Abstract][Full Text] [Related]
9. Solid lipid nanoparticles of Annona muricata fruit extract: formulation, optimization and in vitro cytotoxicity studies. Sabapati M; Palei NN; C K AK; Molakpogu RB Drug Dev Ind Pharm; 2019 Apr; 45(4):577-586. PubMed ID: 30663427 [TBL] [Abstract][Full Text] [Related]
10. Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis. Chokshi NV; Khatri HN; Patel MM Drug Dev Ind Pharm; 2018 Dec; 44(12):1975-1989. PubMed ID: 30058392 [TBL] [Abstract][Full Text] [Related]
11. Clinical comparative study of optimized metronidazole loaded lipid nanocarrier vaginal emulgel for management of bacterial vaginosis and its recurrence. Badawi NM; Elkafrawy MA; Yehia RM; Attia DA Drug Deliv; 2021 Dec; 28(1):814-825. PubMed ID: 33899634 [TBL] [Abstract][Full Text] [Related]
12. Exemestane encapsulated polymer-lipid hybrid nanoparticles for improved efficacy against breast cancer: optimization, Rizwanullah M; Perwez A; Mir SR; Alam Rizvi MM; Amin S Nanotechnology; 2021 Jul; 32(41):. PubMed ID: 34198267 [TBL] [Abstract][Full Text] [Related]
13. Optimization of atorvastatin and quercetin-loaded solid lipid nanoparticles using Box-Behnken design. Lalchandani DS; Chenkual L; Sonpasare K; Rajdev B; Naidu V; Chella N; Porwal PK Nanomedicine (Lond); 2024 Jul; 19(17):1541-1555. PubMed ID: 39012199 [TBL] [Abstract][Full Text] [Related]
14. Functionalized solid lipid nanoparticles combining docetaxel and erlotinib synergize the anticancer efficacy against triple-negative breast cancer. Chaudhuri A; Naveen Kumar D; Kumar D; Kumar Agrawal A Eur J Pharm Biopharm; 2024 Aug; 201():114386. PubMed ID: 38950717 [TBL] [Abstract][Full Text] [Related]